Key Benefits:
Warned errors in the Resolution of 16 February 2013, of the Universitat de Valencia, for which the plan of studies of the Master University in Research and the National Use of the Drug by the University of Valencia is published Valencia published in the "Official Gazette of the State" number 79 of 2 April 2013, it is appropriate to make the appropriate corrections.
The Annex is replaced by the following:
ANNEX
Plan of Studies of the title of Master's Degree in Research and Rational Use of the Drug by the University of Valencia
Knowledge Branch: Health Sciences
1. Distribution of the plan of studies by type of Matter in ECTS credits:
| of subjects | |
|---|---|
|
|
45 |
|
Optives | 30 |
|
Practices External | - |
|
End of Master | 15 |
|
Credits | 90 |
2. Description of the modules that the curriculum consists of:
Module I: Required Module
| Character | ||
|---|---|---|
|
Required. | Required. | 10 |
| Pharmaceutical Technology. | Required. | 10 |
|
Biofarmacia and pharmacokinetics. | Required. | 10 |
| Sources of information, communication, and data processing in research. | Required. | 15 |
| Total credits to be cured | 45 |
|
Module II: Itinerary I: Research in experimental pharmacology
| Character | ||
|---|---|---|
|
| 10 | |
| 10 | ||
| The_table_table_izq"> Research and Drug Development II. | Optional. | |
| Research and Development III. | Optional. | |
| credits to be cured | 30 | |
Module III: Itinerary II: Biopharmaceutical and Drug Research
| Character | |||||
|---|---|---|---|---|---|
|
| |||||
| 15 | |||||
| 15 | |||||
| V. | Optional. | Optional. |
| ||
| credits to be cured | 30 | ||||
Module IV: Itinerary III: Research for the rational use of the drug
| Character | ||
|---|---|---|
| Therapeutic Update. | Optional. | 10 |
| Quality pharmacotherapeutic. | Optional. | 10 |
|
use of the drug. | Optional. | 10 |
| Total credits to be cured | 30 | |
Module V: Itinerary IV: Clinical Drug Research
| Character | ||
|---|---|---|
|
Optional. |
10 | |
| 10 | ||
| 10 | ||
| The_table_table_izq"> Pharmacoeconomy, legislation, and ethics. | Optional. |
10 |
|
pharmacokinetics, gene therapy, and health management. | Optional. | |
| credits to be cured | 30 | |
Each student will take the 30 ECTS of the chosen Itinerary (optativity modules II, III, IV or V).
Module VI: Master End Job
| Character | ||
|---|---|---|
|
|
| |
|
15 |
15 |
totals to be cured | 15 |
Valencia, November 15, 2013. -Rector, Esteban Jesus Morcillo Sanchez.
